Menu
GeneBe

17-28759337-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001077498.3(FAM222B):c.622T>G(p.Leu208Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

FAM222B
NM_001077498.3 missense

Scores

2
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.50
Variant links:
Genes affected
FAM222B (HGNC:25563): (family with sequence similarity 222 member B) Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14621317).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FAM222BNM_001077498.3 linkuse as main transcriptc.622T>G p.Leu208Val missense_variant 3/3 ENST00000581407.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FAM222BENST00000581407.6 linkuse as main transcriptc.622T>G p.Leu208Val missense_variant 3/31 NM_001077498.3 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 27, 2023The c.622T>G (p.L208V) alteration is located in exon 4 (coding exon 2) of the FAM222B gene. This alteration results from a T to G substitution at nucleotide position 622, causing the leucine (L) at amino acid position 208 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
Cadd
Benign
17
Dann
Benign
0.94
Eigen
Benign
-0.056
Eigen_PC
Benign
-0.044
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.84
T;.;T;T
M_CAP
Benign
0.0081
T
MetaRNN
Benign
0.15
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationTaster
Benign
0.95
D;D;D;D
PrimateAI
Uncertain
0.61
T
REVEL
Benign
0.13
Sift4G
Benign
0.18
T;T;T;.
Polyphen
0.96
.;D;D;.
Vest4
0.39
MutPred
0.24
.;Gain of glycosylation at T205 (P = 0.1379);Gain of glycosylation at T205 (P = 0.1379);Gain of glycosylation at T205 (P = 0.1379);
MVP
0.043
MPC
0.16
ClinPred
0.32
T
GERP RS
2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.090
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-27086355; API